Menu
Menu
SOPHiA GENETICS is proud to participate in the 50th National Congress of the Mexican Association of Human Genetics (AMGH) and the 9th Latin American Congress of Human Genetics, organized by AMGH and the Red Latinoamericana de Genética Humana.
📅 November 12–14, 2025
📍 Hotel Sheraton Buganvilias, Puerto Vallarta, Jalisco, Mexico
As a global leader in data-driven medicine, we are thrilled to join this milestone event, bringing together experts, researchers, and clinicians from across Latin America.
📍 Visit us at Booth 6
Our team will be on-site to showcase how the SOPHiA DDM™ Platform transforms complex genomic data into actionable insights—empowering healthcare professionals to accelerate discovery, enhance diagnosis, and drive precision medicine forward.
We’re excited to be part of the 36th Brazilian Congress of Medical Genetics, joining experts, researchers, and clinicians from Brazil. Our focus this year is on presenting the most recent launch — SOPHiA DDM™ Enhanced Exome Solutions. Visit us at booth #3 to learn how our technology can empower your work in medical genetics.
Discover cutting-edge insights with this on-demand session from the ACGH Congress. Dr. Carlos Santamaría, Head of the Molecular Diagnostics Division at the National Children’s Hospital in Costa Rica, shares real-world experiences with exome sequencing in a national pediatric setting. Followed by Dr. Sevana Yaghoubian, Global Director of Genomics at SOPHiA GENETICS, presenting the SOPHiA DDM™ Exome Enhanced Solutions and their impact on clinical decision-making
SOPHiA GENETICS is pleased to announce its participation in the upcoming HGSA 2025 Congress, taking place in Sydney, Australia. As a leader in data-driven medicine, we look forward to engaging with the genetics and healthcare community at this prominent event.
We invite all attendees to visit us at Booth #5 to discover the latest innovations in our New Generation SOPHiA DDM™ Platform. Our showcase will highlight significant advancements in exome sequencing, as well as our cutting-edge oncology solutions, including MSK-ACCESS® and MSK-IMPACT®, both powered by SOPHiA DDM™.
Join us to learn how SOPHiA GENETICS is advancing precision medicine through robust, multimodal, and globally applicable solutions.
SOPHiA GENETICS is proud to participate in the 70th Anniversary of the SBG Congress, taking place in Belém, Brazil, in 2025. As a global leader in data-driven medicine, we are thrilled to engage with the genetics and healthcare communities at this landmark event.
📍 Visit us at Booth #5
Our team will be on-site to showcase how SOPHiA GENETICS is transforming complex genomic data into actionable insights—empowering clinicians and researchers worldwide.
Discover the New Generation SOPHiA DDM™ Platform
Explore our most recent innovations in Exome Sequencing, and learn how they are advancing the diagnosis and resolution of complex genetic cases.
Save the date! Corporate Workshop
Date: August 15
Time: 1:00 pm - 2:00 pm
Hangar 2 Room
Title: Unraveling Complex Genetic Disorders via Exome Sequencing
Speakers:
Dra. Ilana Zalcberg Renault, Onco-hematologist, Dasa Genômica
Bruno Piovezan, Subject Matter Expert, SOPHiA GENETICS
As the global healthcare research landscape evolves at lightning speed, we need to change the way we approach healthcare data by breaking down silos, fostering knowledge sharing, and democratizing access to anonymized real-world health insights. And as the volume and complexity of healthcare data continue to grow, the integration of next-generation data analytics and artificial intelligence is reshaping germline variant analysis, offering researchers the tools to uncover actionable insights, streamline processes, and tackle some of the field’s most pressing challenges.
This webcast will explore how to unlock the potential of germline research with cutting-edge advancements in AI-powered workflows, highlighting the New Generation SOPHiA DDM Platform.
Built by users, for users, this AI-powered platform unites healthcare institutions worldwide, paving the way for a future of collective intelligence in precision medicine by streamling sequencing data analysis and interpretation, simplifying variant prioritization, and accelerating reporting.
What will you learn?
Watch on-demand the webinar “Maximizing Efficiency: Implementing an Enhanced Exome Solution Across Multiple Indications”, where Dr. Eirikur Briem, Head of Department of Genetics and Molecular Medicine at the Landspitali University Hospital in Iceland presents his institute’s experience in implementing the SOPHiA DDM™ Enhanced Exome Solutions.
Filmed as part of the Swiss Biotech Day on May 5th 2025.
An engaging panel discussion on the transformative role of AI-powered technology in building scalable, high-performance healthcare solutions. Discover how collaboration drives innovation and advances precision medicine.
Discussion summary:
Artificial intelligence and big data are revolutionizing biotech and healthcare, driving breakthroughs in precision medicine, clinical decision-making, and drug discovery. This panel showcases how adaptive our autonomous AI models enhance decision-making and improve industry performance and productiivity. Additionally, the discussion will emphasize the importance of robust AI infrastructure in creating scalable, high-performance healthcare solutions, while also highlighting the necessity of strong, high-quality data for accurate AI concepts.
Experts will delve into advancements in clinical development productivity, patient data analytics, AI-powered diagnostics, and the agent-based concepts, while also highlighting local initiatives designed to foster collaboration and innovation in healthcare AI.
Moderator:
Panellists:
We’re thrilled to be back at International Congress of Pathology and Laboratory Medicine (ICPALM 2025)
Join SOPHiA GENETICS at Booth S26 as we showcase our latest breakthroughs in data-driven medicine. Discover how our advanced solutions are transforming clinical insights across Liquid Biopsy, Solid Tumors, Hematologic Malignancies, and more.
We look forward to connecting with you in person in Malaysia!
SOPHiA GENETICS is excited to join the ACGH 2025 Congress in Cartagena, Colombia! Meet us at booth #15 to discover the latest innovations of the New Generation SOPHiA DDM™ Platform, with a special focus on Exome advancements. This event is a key milestone for the scientific and academic community, reinforcing Colombia’s leadership in human genetics. Let’s shape the future of genomics together!
Save the date! Sponsored Academic Lunch
June 12th | 1:00-2:00pm | Room 3
Title
From Data to Diagnosis: The Impact of Enhanced Exomes in Precision Medicine
Speakers
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.